Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

A holistic approach emphasizes lifestyle choices, nutrition, exercise, stress management, medications where appropriate, and ...

Kim said that the most significant cybersecurity threat is social engineering. This is general email phishing and phishing ...

The opening keynote session at HIMSS25, being held at the Venetian Sands Convention Center this week, spotlighted the ...

The dispute between China and the Philippines over the West Philippine Sea (WPS) would not affect the government’s plan to put up a mega economic zone in Iwahig Prison and Penal Farm situated (IPPF) ...

HIMSS President and CEO Hal Wolf shares an overview of the annual global conference and exhibition, taking place in early ...

HHS Secretary Robert F. Kennedy Jr. is proposing to strip public participation from much of the business his agency conducts ...

Healthcare leaders may still be looking for ROI and sustainability, but they know AI is here to stay, and they want to make sure they’re on the right path.

Delivering insights and value through interoperability Industry-wide progress on interoperability has not met the expectations of clinicians and patients. At HIMSS, athenahealth will highlight its ...

Amid the threats to the Education Dept. and reports that Musk’s DOGE had gained access to student loan borrower data, consumer advocates are issuing warnings.